A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC)

A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC)

Bibliographic Details
Main Authors: A. Papatsoris, C. Fragkoulis, E. Fragkiadis, A. Pinitas, K. Tzannis, N. Gavalas, K. Stravodimos, K. Ntoumas, D. Mitropoulos, K. Constantinides, E. Giannopoulou, A. Bamias, C. Deliveliotis
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320333747

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320333747

Similar Items